RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
44 hedge funds and large institutions have $18.7M invested in Regulus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.68% less ownership
Funds ownership: 3.76% → 3.08% (-0.68%)
56% less capital invested
Capital invested by funds: $42.6M → $18.7M (-$23.8M)
Holders
44
Holding in Top 10
–
Calls
$376K
Puts
$343K
Top Buyers
| 1 | +$273K | |
| 2 | +$206K | |
| 3 | +$188K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$169K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$168K |
Top Sellers
| 1 | -$5.02M | |
| 2 | -$1.67M | |
| 3 | -$1.31M | |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$526K |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$435K |